MedPath

EISAI (SINGAPORE) PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

26

HSA:26

Drug Approvals

LEQEMBI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/ML

Approval Date
May 2, 2025
HSA

JYSELECA FILM-COATED TABLET 100MG

Approval Date
Mar 27, 2024
HSA

JYSELECA FILM-COATED TABLET 200MG

Approval Date
Mar 27, 2024
HSA

GOOFICE FILM-COATED TABLET 5MG

Approval Date
Oct 2, 2023
HSA

EQUFINA FILM-COATED TABLET 50MG

Approval Date
Sep 28, 2022
HSA

FYCOMPA ORAL SUSPENSION 0.5MG/ML

Approval Date
Jun 10, 2022
HSA

DAYVIGO FILM-COATED TABLET 5MG

Approval Date
Sep 15, 2021
HSA

DAYVIGO FILM-COATED TABLET 10MG

Approval Date
Sep 15, 2021
HSA

INOVELON FILM-COATED TABLET 200 MG

Approval Date
Jan 5, 2017
HSA

TECFIDERA GASTRO-RESISTANT HARD CAPSULES 120 MG

Approval Date
Jul 26, 2016
HSA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.